The new group combines world-class implant and instrumentation platforms with development and regulatory expertise to offer faster, smarter solutions for OEMs worldwide, setting a new standard for innovation, speed-to-market, and strategic partnership across the industry.

It is backed by a consortium of leading private investors, led by Montagu. 

A NEXT-GENERATION CDMO+ PLATFORM

The group unites the complementary strengths of three leading organizations into one comprehensive, innovative offering of:

  • FDA-cleared and CE-marked technologies including PEEK interbodies, plates, screws, sternal closure systems, cabling, flexible reamers, handles and the SMADE IoT surgical asset tracking system
  • Decades of clinical experience designing, developing, manufacturing and sustaining systems for Trauma, Extremities, Sports Medicine, Spine and Cardio-thoracic markets
  • Scaled, agile operations with approximately 1,500 employees across 12 vertically integrated sites on three continents, and best-in-class equipment allowing for cost-efficient manufacturing of the highest precision and quality.
  • Flexible end-to-end model supporting the full spectrum of our customers’ needs including contract manufacturing, co-development, and private labeling as a manufacturer of record – all at scale.
  • Comprehensive portfolio and expertise in precision manufacturing of surgical instruments, implants and sterilization containers, enabling accelerated development processes and simplifying supply chain management for our OEM customers
  • Unique regulatory capabilities including filing and sustaining 510(k), EUMDR, CE-mark registrations for Class I, II and III surgical devices.

Together, the group is built to support the full continuum of medical devices product development and manufacturing, blending speed, scale, and deep specialization.

“This is more than a merger – it’s a shared ambition to provide solutions that shape the future of musculoskeletal care.“
Salvatore Guccione,
Chairman and interim CEO of the newly formed company

MORE THAN MANUFACTURING

Intech has been pushing the boundaries of complex engineering and manufacturing challenges for over 20 years, remaining at the forefront of innovation alongside its OEM customers, including in the most stringent domains of complex instrumentation, navigation systems, and surgical robotics. 

Beyond Intech’s global contract manufacturing capabilities, the “+” in CDMO+ reflects the group’s ability to deliver end-to-end lifecycle support. Leveraging Tyber and Resolve’s integrated strength in clinical evaluation, regulatory registration, and post-market surveillance, we help OEMs accelerate product development, approval, and commercialization.

“By combining our strengths, we are supporting our OEMs with faster time-to-market, broader capabilities, and the confidence of a truly global partner.”
Jeff Tyber,
Founder & CEO at Tyber Medical and now President of the CDMO+ business

With over 100 510(k)-cleared implant systems, thousands of pre-validated devices, and modular instrumentation, the group helps customers accelerate time-tomarket and bring products to market efficiently through a single, trusted partner.